Last reviewed · How we verify

NCT03842046: NOR-PHEN

Prevention of Hypotension During Cesarean Section

Completed NA Last updated 26 May 2020
What this trial tests

NA trial testing phenylephrine infusion in Hypotension Symptomatic in 82 participants. Completed in 31 August 2019.

Timeline
16 February 2019
Primary endpoint
31 August 2019
31 August 2019

Quick facts

Lead sponsorAretaieion University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment82
Start date16 February 2019
Primary completion31 August 2019
Estimated completion31 August 2019
Sites2 locations across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Aretaieion University Hospital

Who can join

Adults 18 to 48, female only, with Hypotension Symptomatic or Obstetric Anesthesia Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this double-blind randomized study will be to compare a fixed-rate prophylactic noradrenaline infusion to a fixed-rate prophylactic phenylephrine infusion during elective cesarean section under combined spinal-epidural anesthesia

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of phenylephrine infusion

Trials testing the same drug.

Other recruiting trials for Hypotension Symptomatic

Currently open trials in the same condition.

Other Aretaieion University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03842046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing